Pancreatic cystic lesions are being recognized with increasing frequency because of the widespread use of cross-sectional imaging. Although most pancreatic cysts are incidentally detected, pancreatic cysts represent a wide spectrum of histopathology, and neoplastic cysts are more prevalent than previously estimated. Some histologic types have malignant potential. Considering the incidence of perioperative morbidity in patients undergoing surgical resection, deciding whether to operate on or observe an indeterminate pancreatic cyst is challenging. This clinical dilemma has created the need to develop a minimally invasive approach for treating pancreatic cysts. EUS-guided pancreatic cyst ablation has been investigated in several clinical trials and has the potential to become an alternative to surgical resection. (Korean J Med 2014;87:279-283) 

